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Abstract
Background Cerebrovascular disease represents a major
source of global mortality and morbidity. Imaging examina-
tions play a critical role in the management of stroke
patients, from establishing the initial diagnosis to determin-
ing and guiding further treatment.
Methods In this article, current CT and MRI methods
employed in the management of stroke patients are
reviewed, with an emphasis on ischemic stroke.
Results The advantages and disadvantages of these techni-
ques are discussed, a number of cases emphasizing key
points are presented, and a comparison between modern
CT and MRI techniques is outlined.
Conclusion The major drawback of CT is the high radiation
dose, while in MRI it is the more complicated and time-
consuming aspect of the examination.
Main Messages
• Cerebrovascular disease represents a major source of
global mortality and morbidity
• Imaging examinations play a critical role in the manage-
ment of stroke patients
• The penumbra may be seen with both CT and MRI;
however, this concept may be overly simplistic
• The major drawback of CT is the high radiation dose,
while MRI is a more complicated examination
Keywords Cerebrovascular stroke . Magnetic resonance
imaging . Computed tomography, spiral . Perfusion imaging
Introduction
Cerebrovascular disease represents a major source of global
mortality, with over 6 million deaths documented annually,
and is the second leading cause of death in all income
groups worldwide, exceeded only by ischemic heart disease
[1]. In addition to being a leading source of mortality,
cerebrovascular disease is also a significant cause of mor-
bidity. As many as 50 % of stroke survivors do not regain
functional independence, and 20 % require institutional care
3 months after stroke onset [2].
Stroke, or cerebrovascular accident, is characterised by
the onset of neurological symptomatology that most often
includes hemiparesis, aphasia or hemianopia (paraparesis is
not typical for stroke and suggests an ischemic lesion in the
spinal cord or other non-ischemic etiology). The onset may
be sudden or discovered after arousal, and may be accom-
panied by headache, vomiting, vertigo or loss of conscious-
ness. Stroke can be generally classified as ischemic or
hemorrhagic. Treatment strategies for these two subtypes
of stroke are markedly different, and the early diagnosis of
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stroke as well as determination of the subtype is an impor-
tant early step in stroke management.
Hemorrhagic stroke, or intracerebral hemorrhage, repre-
sents 10–15 % of stroke cases. Although the incidence of
this type of stroke is low, it is associated with significant
morbidity and mortality. Up to 38 % of patients that expe-
rience hemorrhagic stroke will die within 30 days [3], and
approximately half of survivors will remain dependent on
others for activities of daily living [4]. Ischemic stroke is
more common, representing approximately 85 % of all
stroke cases, and has a much lower 30-day mortality rate
at approximately 12 % [2]. Morbidity in ischemic stroke
may also be severe and is highly dependent upon timely
diagnosis and initiation of treatment. An ischemic lesion
may also undergo hemorrhagic transformation. This is
especially typical for infarction caused by venous occlusion.
When hemorrhagic infarction is detected, occlusion of the
venous (sinus) system should be considered. Additionally,
transient ischemic attack (TIA) may occur, which involves
focal neurological deficit that resolves within 24 h.
Although self-limited, TIA may complicate the diagnosis
of ischemic stroke. A TIA is also a strong short-term risk
factor for stroke, as up to 20 % of patients that have a TIA
will suffer a stroke within 90 days [2].
The expression “time is brain” relates to the time-
dependent outcome in stroke management, and reflects the
fact that the final infarct volume in ischemic stroke is
dependent not only on regional cerebral blood flow (rCBF,
ml/100 mg/min), but also on the length of time that rCBF
has been reduced. There have been efforts to establish
certain rCBF thresholds for functional and irreversible
impairment in brain ischemia. Generally, rCBF<50 is con-
sidered hypoperfusion, with oligemia occupying the 20–50
range, and ischemia <20. The border between oligemia and
ischemia is that point at which functional impairment man-
ifests, called the functional threshold, and has been experi-
mentally determined in a number of controlled animal
studies [5, 6]. The point at which functional impairment
becomes irreversible impairment, or infarction, is more dif-
ficult to define clearly and is related to the depletion of
intracellular ATP and the subsequent loss of membrane
integrity. The threshold for infarction may also be modulated
by additional factors, such as changes in glucose metabolism
leading to an increase of lactate, the influx of Ca2+ ions into
the cell and the release of excitatory amino acids [7]. Recently,
the role of glutamate in the development of the final ischemic
volume has been emphasised. The release of large amounts of
glutamate may lead to cortical spreading depression (CSD)
and peri-infarct depolarizations (PID) that further tax the
energy capabilities of ischemic cells [8, 9]. It has been exper-
imentally proven that during the first 3 h after ischemia, each
depolarization increases the infarct volume by roughly 20 %
[10]. Conversely, a history of TIA has been shown in some
studies to impart a certain degree of neuroprotection, likely
gained as a lasting adaptive cellular response to ischemia
[11, 12].
Regardless of modulating factors, the development of
irreversible ischemia remains highly time dependent. An
rCBF of 17–18 may be reversible at durations approaching
infinity, while an rCBF<9 likely represents the lower border
of reversibility within an interventional time frame that is
realistically achievable in the clinical setting [13]. The zone
positioned between the functional threshold and the infarc-
tion threshold is called the penumbra, and is considered to
be the volume of ischemic tissue that can potentially be
salvaged if reperfused. As time elapses, the infarction
threshold increases and the penumbra decreases in volume.
In more practical terms, while an rCBF of <9 will in many
cases lead to infarction within 20–30 min, at 60 min the
threshold may be an rCBF<12, and at 45 min<14. There-
fore, the successful management of ischemic stroke is
dependent upon establishing the diagnosis and initiating
treatment as quickly as possible.
Thrombolytic agents are the treatment of choice in ische-
mic stroke, within certain limits. Although temporal guide-
lines for the administration of these agents vary by country
and region, 3 h from the known onset of clinical manifes-
tations to the time of treatment is universally considered a
safe and effective interval. Preconditions for thrombolytic
treatment include, but are not limited to, the exclusion of
hemorrhage and the demonstration of salvageable tissue.
Therefore, characterisation of the penumbra plays a vital
role in the workup of ischemic stroke. Additionally, charac-
terization of the penumbra may allow a more individualised
treatment approach. The 3-h interval between manifestation
and treatment was arrived at following large randomised
trials and may in some cases be too restrictive [14, 15]. It
has been shown that patients with certain perfusion charac-
teristics may benefit from thrombolytic treatment beyond
the 3-h window [16–19]. Ideally, studies such as these
would enable clinicians to make treatment decisions based
upon objective findings unique to the patient rather than
arbitrary time constraints. This would be of obvious benefit
to the large group of patients that present with an unknown
time of onset. However, there are many pitfalls and con-
founders that complicate relying solely on imaging findings,
as will be discussed below.
Imaging
A number of clinical tests have been developed over the
years to help determine the presence of stroke [e.g., 20, 21].
Although these tests may aid in the initial triage of acute
neurological patients, they cannot match the sensitivity and
specificity of an imaging examination, nor is there any
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clinical test available that can accurately differentiate ischemic
and hemorrhagic stroke [22]. Therefore, the initial step in the
management of a suspected stroke patient is an imaging
examination. A non-contrast computed tomography (CT)
examination, often employed at this stage, can quickly
exclude the presence of hemorrhage. The absence of hemor-
rhage supports the diagnosis of an ischemic event, and some
evidence of ischemia may be seen in the native CT as well.
The hyperdense vessel sign and signs related to the loss of
contrast between the gray and white matter (such as the insular
ribbon sign and lentiform obscuration) are all examples of
signs of acute ischemia on native CT (Fig. 1). The imaging
examination also serves to exclude other pathologies that may
resemble stroke clinically, known as the “stroke mimics.”
Such pathologies include, but are not limited to, spinal stroke,
hemorrhagic neoplasms, encephalitis, multiple sclerosis, pos-
tictal (Todd’s) paresis, some types of migraine, intoxications,
hypertensive encephalopathy, hyper- or hypoglycemia, as
well as psychiatric diseases (Fig. 2). Ischemic events, often
of transitory duration, may also have their origin in arteriove-
nous malformations. A steal phenomenon may be responsible
for the symptomatology in these cases although this concept is
controversial (Fig. 3) [23]. Additionally, the distinction
between ischemic stroke following arterial occlusion and
ischemia following venous sinus occlusion with secondary
hemorrhage is important. The treatment of venous occlusive
disease is different from primary stroke, and the prognosis of
the patient fully depends upon early diagnosis (Fig. 4). Mag-
netic resonance imaging (MRI) is usually more sensitive and
specific in distinguishing both the stroke mimics and second-
ary ischemic lesions. Finally, the application of a contrast
agent may increase the specificity of imaging. Especially
contrast-enhanced MRI can reveal a typical cortical pattern
of ischemic enhancement and/or help to detect other patholo-
gies that belong to the stroke mimics.
CT and MR angiography
Imaging the vessels, the origin of all stroke pathology, is an
essential part of the stroke protocol and follows the initial
native CT. Imaging of the vertebral and carotid arteries,
preferably from the aortic arch to the circle of Willis, its
major branches and the initial branches beyond, should be
covered. Angiography improves diagnostic precision, pro-
viding insight into the source of dysfunction, and may lead
the management towards intervention [24, 25]. Both CT and
MR angiography may be used, each maintaining some
advantages and disadvantages.
When the state-of-the-art CT scanners are employed, a
single bolus of contrast agent is sufficient to achieve both
angiography and perfusion images. Thus, CT angiography
requires the application of a contrast agent, but its resolution
is always better than that of MR angiography. However, in
detecting the occlusion of a larger artery such as the middle
carotid artery (MCA), both CT and MR angiography are
usually straightforward (Fig. 1). MCA occlusion is the most
common target of interventional stroke treatment [26]. MR
brain angiography in the stroke protocol is non-contrast in
most cases and is based on the inflow of fresh spins into the
imaging slice, called the time-of-flight (TOF) technique.
One limitation of MR angiography is that the aortic arch is
not covered. Another non-contrast technique, phase-contrast
angiography, is rarely used in stroke management, but is a
valuable tool in detecting venous sinus thrombosis, which
often leads to stroke. CT angiography source data may also
be used for an estimation of the final infarct volume,
similar to DWI in MRI. Furthermore, using this tech-
nique it is possible to distinguish patients at risk of
infarct growth according to the status of the collateral
circulation [27].
Perfusion imaging
The goal of perfusion imaging is not only the diagnosis of
ischemia, but also the detection of the penumbra. In order to
quantify and more precisely detect brain perfusion, several
standard flow parameters are calculated (Fig. 5). Mean
transit time (MTT, s) represents the mean time required for
a volume to clear the capillaries, while the time-to-peak
(TTP, s) reflects the time required for a volume to reach
Fig. 1 Acute obliteration of the
left MCA in an 82-year-old
female. a Hyperdense artery
sign suggesting an acute
thrombus in the left MCA.
b CT angiography shows
obliteration of the left MCA.
c VRT reconstruction. MCA,
middle cerebral artery; VRT,
volume-rendering technique
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peak concentration. Both MTT and TTP are very sensitive to
local perfusion disturbances, but less specific to ischemia or
infarction [28]. Cerebral blood volume (CBV, ml/100 g
brain) represents the volume of blood in a volume of tissue,
and reflects autoregulation. As perfusion pressure decreases,
autoregulatory mechanisms are activated, locally resulting
in vasodilatation and recruitment of supporting capillary
networks to increase perfusion of the ischemic region. The
results of these changes are increased CBV, MTT and TTP.
Within the ischemic core there is a failure of autoregulation,
and CBV is ominously decreased in this region. Cerebral
blood flow (CBF, ml/100 g brain/min) represents the deliv-
ery of blood to tissue per unit time and is calculated by
dividing the CBV by MTT. CBF is decreased in all hypo-
perfused regions, including both the penumbra and ischemic
core. On perfusion CT, CBV has been shown to correlate
with infarct volume [29], and the subtraction of CBF and
CBV is the usual way to detect the penumbra. With MRI,
diffusion-weighted imaging (DWI) is considered to corre-
late with infarct volume [30], and subtraction between CBF
and DWI is used to demonstrate the penumbra. A
comparison between MR and CT perfusion is presented
in Table 1.
Perfusion computed tomography (PCT)
The introduction of perfusion computed tomography (PCT)
of the brain significantly improved the sensitivity and spec-
ificity in detecting fresh ischemia [28]. Perfusion deficit can
be detected immediately after stroke, i.e., in the time when a
standard CT is still negative (Fig. 5). A major disadvantage
of this technique is the limited coverage of the brain with
older scanners. In such cases the coverage is limited to
several slices, and the neurologist or neuroradiologist has
to decide which part of the brain should be covered. It may
happen that misleading neurological symptomatology leads
the physician to set the perfusion slab in the wrong position.
An example may be setting the covered area around the
basal ganglia with the ischemia located in the upper subcor-
tical/cortical areas, or ischemia in the posterior fossa without
cerebellar symptomatology or alternating hemiparesis, thus
mimicking supratentorial involvement. Therefore, 75-mm
brain coverage is the minimal PCT coverage recommended
in selecting patients with acute stroke for reperfusion ther-
apy [31]. However, the emergence of state-of-the-art CT
scanners enables coverage of almost the whole brain and
has resolved this limitation.
Another drawback of CT is the high radiation dose. CT is
considered to be a major source of radiation in developed
Fig. 2 A 20-year-old female with sudden onset of neurological symp-
tomatology. a FLAIR image shows an area of increased signal intensity
in the right angular region. b ADC map does not show restricted
diffusion that would be characteristic for an acute ischemic stroke.
Encephalitis was proven by CSF examination. FLAIR, fluid attenuated
inversion recovery; ADC, apparent diffusion coefficient; CSF, cerebro-
spinal fluid
Fig. 3 A 55-year-old male with sudden onset of transitory aphasia. a
DWI (b-factor 1000) shows an area of restricted diffusion in the left
parietal region. b PD-weighted SE image shows an AVM in the pineal
region. c DSA proves a combined pial-dural AVM. Although the
precise pathogenesis of acute neurological symptomatology in a patient
with an AVM is unknown, the “steal phenomenon” may play a role in
its development. DWI, diffusion-weighted imaging; PD, proton densi-
ty; SE, spin echo; AVM, arteriovenous malformation; DSA, digital
subtraction angiography
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countries [32]. Although ultrafast CT scanners together with
iterative reconstructions can significantly reduce the radia-
tion dose in some applications, such as abdominal or cardiac
CT, in perfusion CT of the brain the dose still remains
relatively high (mean effective dose is approximately
5 mSv) [33]. Additionally, the long reconstruction times of
iterative techniques, in the range of minutes, are inconve-
nient for stroke patient management. There are however
techniques that are able to decrease the radiation dose to
values comparable to unenhanced brain CT (approximately
2 mSv). A decrease from 140–120 kV to 100–80 kV not
only significantly lowers the radiation dose, but also
increases the prominence of the contrast agent because of
the greater importance of the photoelectric effect for 80-kV
photons [34]. Another method for dose reduction relies on
decreasing the image frequency of acquisition from the PCT
first-pass data [35].
PCT enjoys a number of advantages as it is fast, widely
available, and cost effective. Furthermore, there are few
restrictions in the CT environment. However, CT is less
sensitive and less specific in the detection of ischemia than
MRI. Other lesions, such as acute demyelinating plaques,
inflammatory lesions and some brain tumors, may mimic
brain ischemia on CT [36]. A number of pitfalls need to be
considered in performing PCT as well. The operator-
dependent selection for the arterial input function may have
a substantial influence on the results, especially in subjects
with chronic vascular conditions such as giant aneurysm or
carotid artery occlusion, as well as in patients with asym-
metric microvascular changes [37]. Postictal changes are
another concern, as lateralised postictal hyperperfusion
may lead to the erroneous diagnosis of contralateral ische-
mia on visual inspection of colour maps [38]. Furthermore,
postprocessing and modeling methods may affect the results
and may complicate comparison across studies [39].
MR perfusion
Although there has been a great deal of interest in using
MRI in the acute workup of stroke, it remains largely
academic. MRI is known to generally be more sensitive
than CT in the detection of ischemia, and current experi-
mental MRI studies with Na23 show even better sensitivity
for acute stroke imaging [40]. However, the detection of
hemorrhage, especially smaller hemorrhage, is not so
straightforward with MRI. Diamagnetic oxyhemoglobin
present in fresh hemorrhage only changes the proton densi-
ty, the least sensitive MRI parameter, and not the relaxation
times that are primarily responsible for signal intensity on
MR images. This disadvantage has since been balanced with
the introduction of susceptibility-weighted imaging (SWI), a
Fig. 4 Acute hemorrhagic infarction in the right thalamus due to
venous sinus occlusion in a 30-year-old woman with a history of
hormonal contraception. a FLAIR image and b gradient-echo T2*-
weighted image proving hemorrhagic transformation. FLAIR, fluid-
attenuated inversion recovery
Fig. 5 Acute ischemic stroke
due to obliteration of the left ICA
and MCA. a Non-contrast CT is
practically normal, with no
hypodense areas and no mass
effect present. bCBFmap shows
hypoperfusion (colder colours)
in the region of the left MCA. c
CBV map with only subtle dif-
ferences between left and right
hemispheres. d TTP map dis-
plays a significant delay in the
region of the left MCA due to
collateral flow. e CT angiogra-
phy displays obliteration of the
left MCA. ACI, internal carotid
artery; MCA, middle cerebral
artery; CBF, cerebral blood flow;
CBV, cerebral blood volume;
TTP, time-to-peak
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technique that is able to detect even small amounts of
paramagnetic deoxyhemoglobin, which is always present
in fresh hemorrhage [41]. However, other disadvantages of
MRI in the management of stroke patients remain, such as
its relatively longer duration and more restrictive environ-
ment. Patients that are disorientated or unconscious cannot
provide a reliable personal history regarding the presence of
any implanted devices or prostheses.
The major advantages of MRI are whole brain coverage
with a standard scanner, absence of radiation and relatively
safe contrast applied in lower doses, between approximately
10–20 ml (Fig. 6). In addition, a recent MRI technique
called arterial spin labeling (ASL) enables basic perfusion
imaging without the administration of a contrast agent. This
technique, which enables the quantitative measurement of
CBF, is based on magnetic labeling of blood prior to flowing
into a volume of interest, typically in the neck (i.e., in the
common carotid arteries). An inversion pulse is used to tag
inflowing spins proximal to the imaging slab, and, following
a certain delay to allow these spins to enter the imaging slab
and exchange with protons in the tissue, control and label
images are obtained [42]. A subtraction technique is then
used for the final image calculation (Figs. 7, 8). Signal
change caused by spin labeling is directly proportional to
blood flow (CBF increase of ∼1 ml/100 g tissue/min
increases signal by ∼1 %); therefore, CBF data can be easily
calculated [43]. Labeling can be either continuous (CASL)
or pulsed (PASL). In CASL, blood is labeled even during
the readout phase. This approach requires a special labeling
coil and has a higher signal-to-noise ratio (SNR) with a
penalty of higher specific absorption rate (SAR) [44]. There-
fore, PASL is more commonly used at 1.5 T and 3 T. With
this approach, a saturation pulse is followed by a short
delay, and then an echo-planar image of an area of interest
is acquired. PASL benefits from higher SNR and T1 pro-
longation at 3 T. Several acquisition schemes for PASL exist
(with QUIPPS II being commonly used) and are available as
products from major vendors. The drawbacks of ASL are
longer acquisition times and measurement of CBF only, as
with ASL it is currently not possible to calculate MTT, TTP
or CBV. The main advantage is the ability to perform
imaging without the use of contrast, which can be crucial
in subjects with known allergy, high risk of nephrogenic
systemic fibrosis or in longitudinal studies. Although ASL
and SWI improve the utility of MRI in stroke management,
in many centres these techniques are not yet part of routine
clinical practice.
Penumbra detection
Different parameters are used in routine clinical practice for
the detection of penumbra with CT and MRI. The subtrac-
tion of CBF and CBV is the usual way to detect penumbra
using CT. On MRI, a subtraction between perfusion param-
eters (MTT, TTP or CBF) and DWI, rather than CBV, is
used (Fig. 7). This is due to the fact that CBV (especially on
Table 1 Comparison between MR and CT perfusion
CT MRI
Detection of hemorrhage Detection of hemorrhage with SWI
Angiography, better resolution Angiography, non-contrast
Faster, more available,
less restrictive
Slower, limited availability,
restrictive environ
Radiation No radiation
Limited in posterior fossa Better detection in posterior fossa
Limited detection of small
lesions
Better detection of small
lesions (DWI)
Less specific in detection
of “stroke mimics”
Better detection of “stroke mimics,”
especially on contrast-enhanced
scans
SWI susceptibility-weighted imaging, DWI diffusion-weighted imaging
Fig. 6 A 34-year-old male with a history of two transient ischemic
attacks and normal neurological examination. Standard MRI was nor-
mal. a DWI (b01,000). b PASL sequence shows hypoperfusion in the
distribution of the right MCA. c Contrast perfusion is concordant with
PASL. DSA shows obliteration of the right MCA with very good
collateral flow from the d ipsilateral and also e contralateral vascular
territories. DWI, diffusion-weighted imaging; PASL, pulsed arterial
spin labeling; MCA, middle cerebral artery; DSA, digital subtraction
angiography
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MRI) is not sensitive enough to detect small lesions below
approximately 10 ml. Such lesions are easily detected
with DWI [45]. DWI, on the other hand, may underes-
timate the final stroke volume and grows into CBV over
the time [46].
The penumbra concept is far from straightforward, how-
ever, as a number of different factors determine whether the
tissue will become necrotic, such as the time-dependent
nature of morphological changes discussed previously. The
situation is even more complicated because exact quantifi-
cation of perfusion values (CBF, CBV) is rarely used in
routine clinical practice. Thus, relying only on CBF/CBV
mismatch might disqualify some patients that would benefit
from intervention (Fig. 8). Several studies have shown that
even in critically hypoperfused tissue, only a part of the
predicted final infarct volume became necrotic after throm-
bolytic therapy [47, 48]. For these reasons, no quantitative
parameters related to the penumbra should currently be
taken for granted, and neuroimaging of the penumbra
based on the presence of mismatch on CT or MRI may
bring ambiguous results in relation to treatment outcome
[7].
Conclusions
In comparing the use of CT versus MRI in the workup of
ischemic stroke, a number of factors come under consider-
ation. When ultrafast CT scanners covering almost the entire
brain are used, the potential to detect ischemia and salvage-
able tissue is almost equal in both techniques. The major
drawback of CT is the high radiation dose, while in MRI it is
the more complicated and time consuming aspect of the
examination. Thus, if any general practical recommendation
can be made, acute stroke patients should be evaluated by
native CT followed by PCT, with MRI reserved for more
chronic cases of brain ischemia or control examinations in
stroke patients. However, when state-of-the-art CT and
high-quality MR scanners are utilised, both techniques are
practically equivalent in the hands of experienced personnel,
Fig. 7 An 86-year-old male with a history of previous ischemic events
developed sudden left-sided hemianopia. a T2-weighted TSE image
with a number of ischemic lesions. b DW image (b01,000) clearly
shows a region of acute ischemia as an area of restricted diffusion. c
PASL image with a perfusion deficit in the right occipital region. TSE,
turbo spin echo; DW, diffusion weighted; PASL, pulsed arterial spin
labeling
Fig. 8 A 41-year-old obese, normotensive female treated with hor-
monal contraception developed left-sided hemiplegia at 6 a.m. a Acute
CT at 7:30 a.m. shows a mild hyperdense lesion in the distribution of
the right MCA and a large perfusion deficit with no penumbra on b
CBF and c CBV maps. At 8:20 a.m. intravenous Actilyse was applied,
and at 10:35 a.m., despite the absence of penumbra, d mechanical
thrombolysis of the obliterated right MCA was performed e with
successful thrombus removal. Left-sided hemiplegia resolved within
a week. Six weeks after the stroke the patient was fully independent,
going to work, driving a car and feeling no limitation of her left
extremities except for “slight clumsiness” of her left hand. f CT scan
with minimal residual ischemic changes. MCA, middle cerebral artery;
CBF, cerebral blood flow; CBV, cerebral blood volume
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and local clinical configurations may often dictate which
technique should be used.
Open Access This article is distributed under the terms of the Crea-
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